Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 14/20 | 0.56 |
| ▸ | ITGA2B | P08514 | 14/20 | 0.56 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.52 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.52 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.52 |
| ▸ | SLC6A12 | P48065 | 2/20 | 0.52 |
| ▸ | SLC6A11 | P48066 | 2/20 | 0.52 |
| ▸ | SLC6A13 | Q9NSD5 | 2/20 | 0.52 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.52 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.52 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.52 |
| ▸ | F2R | P25116 | 6/20 | 0.49 |
| ▸ | GABRP | O00591 | 1/20 | 0.44 |
| ▸ | GABRD | O14764 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.44 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3159636 | 0.98 | ITGB3 (0.54) | ITGB3ITGA2BGABRA5GABRB2SLC6A1 | |
| Acetic Acid SCHEMBL9210574 | 0.94 | ITGB3 (0.51) | ITGB3ITGA2BGABRA5GABRB2SLC6A1 | |
| SCHEMBL5495308 | 0.92 | ITGB3 (0.50) | ITGB3ITGA2BGABRA5GABRB2SLC6A1 | |
| Trifluoroacetic Acid SCHEMBL29890740 | 0.90 | ITGB3 (0.49) | ITGB3ITGA2BGABRA5GABRB2SLC6A1 | |
| SCHEMBL5499043 | 0.87 | SLC6A1 (0.64) | ITGB3ITGA2BGABRA5GABRB2SLC6A1 | |
| SCHEMBL381083 | 0.87 | ITGB3 (0.66) | ITGB3ITGA2BGABRA5GABRB2SLC6A1 | |
| SCHEMBL29207730 | 0.87 | SLC6A1 (0.64) | ITGB3ITGA2BGABRA5GABRB2SLC6A1 | |
| SCHEMBL31370174 | 0.87 | SLC6A1 (0.64) | ITGB3ITGA2BGABRA5GABRB2SLC6A1 | |
| Hydrochloric Acid SCHEMBL25181844 | 0.85 | SLC6A1 (0.62) | ITGB3ITGA2BGABRA5GABRB2SLC6A1 | |
| Hydrochloric Acid SCHEMBL1532653 | 0.85 | ITGB3 (0.64) | ITGB3ITGA2BGABRA5GABRB2SLC6A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 314 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102656180-B | As the feather fan alcohol type triterpene derivative of antiviral drug | HETERO RESEARCH FOUNDATION (IN) | 2016-04-20 | — | — | CN | claimed |
| US-8357654-B2 | Multimeric CD40 ligands, method for preparing same and use thereof for preparing drugs | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-01-22 | — | — | US | claimed |
| US-20100183642-A1 | NOVEL MULTIMERIC CD40 LIGANDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR PREPARING DRUGS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-07-22 | — | — | US | claimed |
| US-20100136034-A1 | NOVEL MULTIMERIC MOLECULES, A PROCESS FOR PREPARING THE SAME AND THE USE THEREOF FOR MANUFACTURING MEDICINAL DRUGS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-06-03 | — | — | US | claimed |
| EP-1828240-B1 | NOVEL MULTIMERIC CD40 LIGANDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR PREPARING DRUGS | CENTRE NAT RECH SCIENT (FR) | 2009-07-29 | — | — | EP | claimed |
| EP-0173585-B1 | MEDICINES BASED ON PIPERIDINE DERIVATIVES, PIPERIDINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | RHONE-POULENC SANTE (FR) | 1988-08-24 | — | — | EP | claimed |
| EP-3966226-B1 | MASP INHIBITORY COMPOUNDS AND USES THEREOF | BAYER AG (DE) | 2025-12-24 | — | — | EP | disclosed |
| US-12503491-B2 | MASP inhibitory compounds and uses thereof | BAYER AKTIENGESELLSCHAFT (DE) | 2025-12-23 | — | — | US | disclosed |
| US-20250230154-A1 | COMPOUND HAVING SHP2 PROTEIN DEGRADING ACTIVITY, AND MEDICAL USES THEREOF | UBIX THERAPEUTICS, INC. (KR) | 2025-07-17 | — | — | US | disclosed |
| US-20250115598-A1 | BIFUNCTIONAL ARYLSULPHONAMIDE COMPOUNDS | Anaxis Pharma Pty Ltd (AU) | 2025-04-10 | — | — | US | disclosed |
| WO-2025070731-A1 | PEPTIDEPEPTIDE | ペプチドリーム株式会社 | 2025-04-03 | — | — | WO | disclosed |
| WO-2025070720-A1 | PEPTIDE | ペプチドリーム株式会社 | 2025-04-03 | — | — | WO | disclosed |
| US-20250059218-A1 | ENPP1 Inhibitors and Methods of Modulating Immune Response | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2025-02-20 | — | — | US | disclosed |
| EP-0035820-A2 | Novel quinoline derivatives, pharmaceutical compositions containing such compounds, and method for the preparation of these compounds | ACF CHEMIEFARMA NV (NL) | 1981-09-16 | — | — | EP | disclosed |
| EP-0035819-A1 | Quinoline derivatives, pharmaceutical compositions containing such compounds, and methods for the preparation of these compounds | ACF Chemiefarma N.V. (NL) | 1981-09-16 | — | — | EP | disclosed |
| EP-0035821-A1 | Quinoline derivatives, pharmaceutical compositions containing such compounds, and method for the preparation of these compounds | ACF Chemiefarma N.V. (NL) | 1981-09-16 | — | — | EP | disclosed |
| US-4289772-A | PHOSPHODIESTERASE INHIBITORS | PFIZER INC. (US) | 1981-09-15 | — | — | US | disclosed |
| EP-0030044-A1 | Quinoline derivatives, processes for their preparation, their use, pharmaceutical compositions containing them and a method for the preparation of these pharmaceutical compositions | ACF CHEMIEFARMA NV (NL) | 1981-06-10 | — | — | EP | disclosed |
| US-4243666-A | HYPOTENSIVE AGENTS | PFIZER INC. (US) | 1981-01-06 | — | — | US | disclosed |
| US-3983173-A | ANTIBIOTIC | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12503491-B2 | MASP inhibitory compounds and uses thereof | MASP2, SERPINB1, SPINT2 | ITGB3 2938/4885ITGA2B 3093/4885GABRA5 3356/4885 |
| US-20100183642-A1 | NOVEL MULTIMERIC CD40 LIGANDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR PREPARING DRUGS | CD40, CD40LG, TNFSF10 | ITGB3 1229/4885ITGA2B 1360/4885GABRA5 2541/4885 |
| US-20250230154-A1 | COMPOUND HAVING SHP2 PROTEIN DEGRADING ACTIVITY, AND MEDICAL USES THEREOF | PTPN1, PTPN5, PTPN2 | ITGB3 4825/4885ITGA2B 4642/4885GABRA5 3597/4885 |
| US-20100136034-A1 | NOVEL MULTIMERIC MOLECULES, A PROCESS FOR PREPARING THE SAME AND THE USE THEREOF FOR MANUFACTURING MEDICINAL DRUGS | TNFRSF1A, TNFRSF9, CD40 | ITGB3 1120/4885ITGA2B 757/4885GABRA5 264/4885 |
| US-20250115598-A1 | BIFUNCTIONAL ARYLSULPHONAMIDE COMPOUNDS | MLKL, CASP1, CASP9 | ITGB3 3939/4885ITGA2B 3908/4885GABRA5 4774/4885 |
| US-20250059218-A1 | ENPP1 Inhibitors and Methods of Modulating Immune Response | ENPP1, STING1, ENPP2 | ITGB3 4836/4885ITGA2B 4655/4885GABRA5 3223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.